Fortress Biotech Ownership | Who Owns Fortress Biotech?


OverviewForecastRevenueFinancialsChartTranscripts

Fortress Biotech Ownership Summary


Fortress Biotech is owned by 5.96% institutional investors, 20.98% insiders, and 73.06% retail investors. Vanguard group is the largest institutional shareholder, holding 3.54% of FBIO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.97% of its assets in Fortress Biotech shares.

FBIO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockFortress Biotech5.96%20.98%73.06%
SectorHealthcare Stocks 42.53%10.81%46.67%
IndustryBiotech Stocks 45.24%10.75%44.01%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group950.33K3.54%$3.51M
Summit financial444.75K1.65%$1.65M
Shikiar asset management278.47K1.04%$1.03M
Geode capital management244.42K0.91%$903.53K
Northern trust220.64K0.82%$815.25K
Sculptor capital lp208.90K0.78%$771.89K
Kestra advisory services196.88K0.73%$727.45K
Blackrock funding, inc. /de189.79K0.71%$701.29K
Hb wealth management120.17K0.45%$444.05K
Ci private wealth95.47K0.36%$352.75K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Shikiar asset management278.47K0.26%$1.03M
Sheets smith investment management73.14K0.18%$270.26K
180 wealth advisors82.50K0.04%$304.84K
Tme financial11.50K0.03%$42.49K
Summit financial444.75K0.03%$1.65M
Scientech research18.07K0.02%$66.78K
Weaver consulting group20.61K0.02%$76.16K
Two sigma securities30.47K0.02%$112.60K
Sculptor capital lp208.90K0.01%$771.89K
Abacus planning group14.53K0.01%$53.70K

Top Buyers

HolderShares% AssetsChange
Sculptor capital lp208.90K0.01%208.90K
Northern trust220.64K0.00%127.41K
Hb wealth management120.17K0.00%120.17K
Vanguard group950.33K0.00%97.41K
Sheets smith investment management73.14K0.18%73.14K

Top Sellers

HolderShares% AssetsChange
Cambridge investment research advisors---1.00M
Summit financial444.75K0.03%-571.10K
Nantahala capital management---325.52K
Envestnet asset management22.29K--147.43K
B. riley wealth advisors---144.70K

New Positions

HolderShares% AssetsChangeValue
Sculptor capital lp208.90K0.01%208.90K$771.89K
Sheets smith investment management73.14K0.18%73.14K$270.26K
Jane street group73.10K-73.10K$270.10M
Simplex trading54.45K0.00%54.45K$201.00K
Hrt financial lp46.13K0.00%46.13K$170.00K

Sold Out

HolderChange
Raymond james financial-26.00
Meridian wealth management-10.00K
R squared-10.17K
Goldman sachs group-11.63K
Creative planning-12.45K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202514-73.08%1,602,201-67.70%51.69%8-70.37%4-69.23%
Jun 30, 2025514.08%4,637,257-5.60%175.08%2728.57%12-
Mar 31, 202548-12.73%4,440,118-7.34%163.16%20-39.39%129.09%
Dec 31, 2024553.77%4,791,9487.76%234.52%3332.00%11-15.38%
Sep 30, 202453-1.85%4,447,05222.70%225.77%25-7.41%138.33%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv585.25K1.97%-12.79K
Vanguard US Total Market Shares ETF470.54K1.59%-
Vanguard Institutional Extnd Mkt Idx Tr200.45K0.67%-52.40K
Fidelity Extended Market Index111.94K0.38%-921.00
iShares Micro-Cap ETF52.19K0.18%-
Fidelity Total Market Index49.77K0.17%-106.00
NT Ext Equity Mkt Idx Fd - NL45.89K0.16%28.57K
NT Ext Equity Mkt Idx Fd - DC - NL - T235.63K0.12%22.15K
Fidelity Series Total Market Index29.00K0.10%-
Spartan Extended Market Index Pool F25.39K0.09%921.00

Recent Insider Transactions


DateNameRoleActivityValue
Sep 23, 2024ROSENWALD LINDSAY A MD PRESIDENT, CEO & CHAIRMANBuy$1.40M
Sep 23, 2024ROSENWALD LINDSAY A MD PRESIDENT, CEO & CHAIRMANBuy$1.40M
Jul 11, 2024ROSENWALD LINDSAY A MD President, CEO & ChairmanBuy$37.42K
Jul 10, 2024Jin David Chief Financial OfficerBuy$3.75K
Jul 09, 2024ROSENWALD LINDSAY A MD President, CEO & ChairmanBuy$36.97K

Insider Transactions Trends


DateBuySell
2025 Q4--
2025 Q2--
2025 Q1--
2024 Q4--
2024 Q36-

FBIO Ownership FAQ


Who Owns Fortress Biotech?

Fortress Biotech shareholders are primarily institutional investors at 5.96%, followed by 20.98% insiders and 73.06% retail investors. The average institutional ownership in Fortress Biotech's industry, Biotech Stocks , is 45.24%, which Fortress Biotech falls below.

Who owns the most shares of Fortress Biotech?

Fortress Biotech’s largest shareholders are Vanguard group (950.33K shares, 3.54%), Summit financial (444.75K shares, 1.65%), and Shikiar asset management (278.47K shares, 1.04%). Together, they hold 6.23% of Fortress Biotech’s total shares outstanding.

Does Blackrock own Fortress Biotech?

BlackRock is not among the top 10 institutional shareholders of Fortress Biotech.

Who is Fortress Biotech’s biggest shareholder by percentage of total assets invested?

Shikiar asset management is Fortress Biotech’s biggest shareholder by percentage of total assets invested, with 0.26% of its assets in 278.47K Fortress Biotech shares, valued at 1.03M$.

Who is the top mutual fund holder of Fortress Biotech shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Fortress Biotech shares, with 1.97% of its total shares outstanding invested in 585.25K Fortress Biotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools